Ocella Kit
Product Images NDC 0555-9131

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Ocella (NDC 0555-9131). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Teva Pharmaceuticals Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

26feec7e 7793 4094 899d C3b40a4f0eba 00

This text provides a list of relevant studies that have evaluated the risk of breast cancer associated with the use of combined oral contraceptives. The studies included in the list compare ever use versus never use of COCs, as well as current use versus never use. The text also includes some statistical information, including effect estimates such as odds ratios (OR), relative risks (RR), and hazard ratios (HR) for the association between COC use and breast cancer risk.*

FDA Label Image

Figure 2 (7ae51f8c 8ea0 4502 8d7b D0c0b1a295ba 02)

This text seems to describe different ranges of blood clot occurrence in women based on various factors such as pregnancy, postpartum period, and use of contraception. It also provides a numerical representation of the blood clot rate per 10,000 Women Years (WY). However, the description is incomplete and lacks context.*

FDA Label Image

Structural Formulas (7ae51f8c 8ea0 4502 8d7b D0c0b1a295ba 03)

Drospirenone Ethinyl Estradiol is a combination of two hormones that are used in birth control pills. Ethinyl estradiol is a synthetic estrogen and drospirenone is a synthetic progestin. This medication works by preventing ovulation and thickening cervical mucus, making it harder for sperm to reach the uterus. It is also used to treat premenstrual dysphoric disorder and moderate acne in women. It is important to take this medication as directed by your healthcare provider to ensure maximum effectiveness and to reduce the risk of side effects.*

FDA Label Image

Pregnancy Diagram (7ae51f8c 8ea0 4502 8d7b D0c0b1a295ba 04)

This text appears to be describing different methods of birth control and the effectiveness rates for each. It provides information on the number of pregnancies per 100 women with and without the use of various birth control methods, including injections, sterilization, birth control pills, condoms, and natural family planning methods such as withdrawal and tracking fertile days. It also mentions some methods by name, including diaphragms and intrauterine devices.*

FDA Label Image

Ocella Foil (7ae51f8c 8ea0 4502 8d7b D0c0b1a295ba 05)

The text contains some weekdays and a brand name "OCELLA™" followed by two drug names, "DROSPIRENONE & ETHINYL ESTRADIOL". There are some numbers and characters as well, but they are not readable. It seems like the text is a part of a schedule or a label, and the drug names are used for some medication.*

FDA Label Image

Blood Clot Diagram (7ae51f8c 8ea0 4502 8d7b D0c0b1a295ba 06)

This text provides information on the rate of blood clot incidents in women who are not pregnant, non-COC users, COC users, pregnant or postpartum. The data consists of ranges and the number of women with a blood clot out of 10,000 women years (WY). It also includes a note about the pregnancy data being based on actual duration or nine months, with a rate of 7-27 per 10,000 WY.*

FDA Label Image

Ocella Trade Carton (7ae51f8c 8ea0 4502 8d7b D0c0b1a295ba 07)

FDA Label Image

Fig 1 (Image 01)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.